130 related articles for article (PubMed ID: 2601336)
1. Progestins and androgens stimulate lipid accumulation in T47D breast cancer cells via their own receptors.
Chambon M; Rochefort H; Vial HJ; Chalbos D
J Steroid Biochem; 1989 Nov; 33(5):915-22. PubMed ID: 2601336
[TBL] [Abstract][Full Text] [Related]
2. Dual effects of the progestin R5020 on proteins released by the T47D human breast cancer cells.
Chalbos D; Rochefort H
J Biol Chem; 1984 Jan; 259(2):1231-8. PubMed ID: 6229532
[TBL] [Abstract][Full Text] [Related]
3. Antiestrogenic effect of R5020, a synthetic progestin in human breast cancer cells in culture.
Vignon F; Bardon S; Chalbos D; Rochefort H
J Clin Endocrinol Metab; 1983 Jun; 56(6):1124-30. PubMed ID: 6682424
[TBL] [Abstract][Full Text] [Related]
4. Growth inhibition and increase of insulin receptors in antiestrogen-resistant T47DCO human breast cancer cells by progestins: implications for endocrine therapies.
Horwitz KB; Freidenberg GR
Cancer Res; 1985 Jan; 45(1):167-73. PubMed ID: 3838085
[TBL] [Abstract][Full Text] [Related]
5. A 250-kilodalton cellular protein is induced by progestins in two human breast cancer cell lines MCF7 and T47D.
Chalbos D; Rochefort H
Biochem Biophys Res Commun; 1984 Jun; 121(2):421-7. PubMed ID: 6539596
[TBL] [Abstract][Full Text] [Related]
6. Progesterone agonists and antagonists induce down- and up-regulation of estrogen receptors and estrogen inducible genes in human breast cancer cell lines.
Savoldi G; Ferrari F; Ruggeri G; Sobek L; Albertini A; Di Lorenzo D
Int J Biol Markers; 1995; 10(1):47-54. PubMed ID: 7629427
[TBL] [Abstract][Full Text] [Related]
7. Identification and androgen regulation of two proteins released by T47D human breast cancer cells.
Chalbos D; Haagensen D; Parish T; Rochefort H
Cancer Res; 1987 Jun; 47(11):2787-92. PubMed ID: 3567903
[TBL] [Abstract][Full Text] [Related]
8. Difference between R5020 and the antiprogestin RU486 in antiproliferative effects on human breast cancer cells.
Gill PG; Vignon F; Bardon S; Derocq D; Rochefort H
Breast Cancer Res Treat; 1987 Oct; 10(1):37-45. PubMed ID: 3689980
[TBL] [Abstract][Full Text] [Related]
9. The anti-progestin RU486 stabilizes the progestin-induced fatty acid synthetase mRNA but does not stimulate its transcription.
Chalbos D; Galtier F; Emiliani S; Rochefort H
J Biol Chem; 1991 May; 266(13):8220-4. PubMed ID: 2022639
[TBL] [Abstract][Full Text] [Related]
10. RU486, a progestin and glucocorticoid antagonist, inhibits the growth of breast cancer cells via the progesterone receptor.
Bardon S; Vignon F; Chalbos D; Rochefort H
J Clin Endocrinol Metab; 1985 Apr; 60(4):692-7. PubMed ID: 3972969
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of 17 beta-estradiol, progestin R5020, tamoxifen and RU38486 on lactate dehydrogenase activity in MCF-7 human breast cancer cells.
Thomas M; Monet JD; Brami M; Dautigny N; Assailly J; Ulmann A; Bader CA
J Steroid Biochem; 1989 Feb; 32(2):271-7. PubMed ID: 2921868
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of T47D human breast cancer cell growth by the synthetic progestin R5020: effects of serum, estradiol, insulin, and EGF.
Gill PG; Tilley WD; De Young NJ; Lensink IL; Dixon PD; Horsfall DJ
Breast Cancer Res Treat; 1991 Dec; 20(1):53-62. PubMed ID: 1813069
[TBL] [Abstract][Full Text] [Related]
13. Progestins induce down-regulation of insulin-like growth factor-I (IGF-I) receptors in human breast cancer cells: potential autocrine role of IGF-II.
Papa V; Hartmann KK; Rosenthal SM; Maddux BA; Siiteri PK; Goldfine ID
Mol Endocrinol; 1991 May; 5(5):709-17. PubMed ID: 1649393
[TBL] [Abstract][Full Text] [Related]
14. Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic adenocarcinoma cell line LNCaP.
Swinnen JV; Van Veldhoven PP; Esquenet M; Heyns W; Verhoeven G
Endocrinology; 1996 Oct; 137(10):4468-74. PubMed ID: 8828509
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors.
Cops EJ; Bianco-Miotto T; Moore NL; Clarke CL; Birrell SN; Butler LM; Tilley WD
J Steroid Biochem Mol Biol; 2008 Jun; 110(3-5):236-43. PubMed ID: 18515094
[TBL] [Abstract][Full Text] [Related]
16. Multiple human progesterone receptor messenger ribonucleic acids and their autoregulation by progestin agonists and antagonists in breast cancer cells.
Wei LL; Krett NL; Francis MD; Gordon DF; Wood WM; O'Malley BW; Horwitz KB
Mol Endocrinol; 1988 Jan; 2(1):62-72. PubMed ID: 3398843
[TBL] [Abstract][Full Text] [Related]
17. Effects of androgens on proliferation and progesterone receptor levels in T47D human breast cancer cells.
Liberato MH; Sonohara S; Brentani MM
Tumour Biol; 1993; 14(1):38-45. PubMed ID: 8493449
[TBL] [Abstract][Full Text] [Related]
18. Progestin stimulation of thymidine kinase in the human breast cancer cell line T47D.
Moore MR; Hathaway LD; Bircher JA
Biochim Biophys Acta; 1991 Feb; 1096(2):170-4. PubMed ID: 2001431
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by nomegestrol acetate and other synthetic progestins on proliferation and progesterone receptor content of T47-D human breast cancer cells.
Botella J; Duranti E; Duc I; Cognet AM; Delansorne R; Paris J
J Steroid Biochem Mol Biol; 1994 Jul; 50(1-2):41-7. PubMed ID: 8049131
[TBL] [Abstract][Full Text] [Related]
20. Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D).
Chalbos D; Vignon F; Keydar I; Rochefort H
J Clin Endocrinol Metab; 1982 Aug; 55(2):276-83. PubMed ID: 7045150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
